Mammen Mathai

CIK 00014210504 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001421050

Recent Transactions

50 trades

Award
10x Genomics, Inc.$TXG
Class A Common Stock
2024-06-11+8,649→ 180,259 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2023-06-14+1,865→ 171,610 total
Award
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2023-06-14+4,661→ 4,661 total
Exercise/Conversion
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2023-05-11−200,000→ 0 total
Exercise/Conversion
10x Genomics, Inc.$TXG
Class A Common Stock
2023-05-11$1.16/sh+200,000→ 202,745 total
Sale
10x Genomics, Inc.$TXG
Class A Common Stock
2023-05-11$52.82/sh−33,000→ 169,745 total
Award
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2022-06-15+5,300→ 5,300 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2022-06-15+2,120→ 2,745 total
Exercise/Conversion
JOHNSON & JOHNSON$JNJ
Common Stock
2022-02-15+7,740→ 45,300 total
Exercise/Conversion
JOHNSON & JOHNSON$JNJ
Performance Share Units
2022-02-15−7,740→ 737 total
Tax Payment
JOHNSON & JOHNSON$JNJ
Common Stock
2022-02-15$165.89/sh−3,366→ 41,934 total
Exercise/Conversion
JOHNSON & JOHNSON$JNJ
Restricted Share Units
2022-02-14−7,418→ 0 total
Award
JOHNSON & JOHNSON$JNJ
Employee Stock Options (Right to Buy)
2022-02-14$165.89/sh+38,736→ 38,736 total
Award
JOHNSON & JOHNSON$JNJ
Restricted Share Units
2022-02-14+3,922→ 3,922 total
Tax Payment
JOHNSON & JOHNSON$JNJ
Common Stock
2022-02-14$168.85/sh−2,335→ 37,560 total
Exercise/Conversion
JOHNSON & JOHNSON$JNJ
Common Stock
2022-02-14+7,418→ 39,895 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2021-06-11+625→ 625 total
Award
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2021-06-11+1,563→ 1,563 total
Award
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2020-06-15+4,432→ 4,432 total
Other
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2019-09-16+200,000→ 200,000 total
Other
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2019-09-16−200,000→ 0 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2016-03-15+90,000→ 288,111 total
Tax Payment
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2016-02-20$15.65/sh−19,844→ 198,111 total
Tax Payment
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2015-11-20$17.17/sh−934→ 217,955 total
Tax Payment
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2015-08-20$12.98/sh−934→ 218,889 total
Tax Payment
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2015-06-02$13.83/sh−7,360→ 219,823 total
Tax Payment
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2015-05-20$14.24/sh−673→ 227,183 total
Tax Payment
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2015-02-20$19.52/sh−674→ 227,856 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2015-02-05+130,000→ 228,530 total
Tax Payment
Theravance Biopharma, Inc.$TBPH
Common Stock
2014-11-20−658→ 80,492 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2014-10-08+170,000→ 170,000 total
Tax Payment
Innoviva, Inc.$INVA
Common Stock
2014-08-20$22.76/sh−3,261→ 334,040 total
Exercise/Conversion
Innoviva, Inc.$INVA
Stock Option (Right to Buy)
2014-03-06−29,250→ 0 total
Exercise/Conversion
Innoviva, Inc.$INVA
Common Stock
2014-03-06$16.00/sh+29,250→ 224,469 total
Exercise/Conversion
Innoviva, Inc.$INVA
Common Stock
2014-03-06$12.40/sh+12,903→ 195,219 total
Exercise/Conversion
Innoviva, Inc.$INVA
Stock Option (Right to Buy)
2014-03-06−12,903→ 0 total
Tax Payment
Innoviva, Inc.$INVA
Common Stock
2014-02-20$39.98/sh−4,307→ 182,316 total
Sale
Innoviva, Inc.$INVA
Common Stock
2014-02-14$39.26/sh−30,400→ 191,223 total
Sale
Innoviva, Inc.$INVA
Common Stock
2014-02-14$40.04/sh−4,600→ 186,623 total
Tax Payment
Innoviva, Inc.$INVA
Common Stock
2013-11-20$36.40/sh−4,569→ 222,073 total
Gift
Innoviva, Inc.$INVA
Common Stock
2013-10-03−450→ 221,623 total
Exercise/Conversion
Innoviva, Inc.$INVA
Common Stock
2013-08-21$16.00/sh+18,750→ 226,642 total
Exercise/Conversion
Innoviva, Inc.$INVA
Stock Option (Right to Buy)
2013-08-21−18,750→ 0 total
Tax Payment
Innoviva, Inc.$INVA
Common Stock
2013-08-20$35.89/sh−3,813→ 207,892 total
Sale
Innoviva, Inc.$INVA
Common Stock
2013-07-30$36.51/sh−7,000→ 211,705 total
Award
Innoviva, Inc.$INVA
Common Stock
2013-07-24+5,000→ 218,705 total
Exercise/Conversion
Innoviva, Inc.$INVA
Stock Option (Right to Buy)
2013-05-29−6,451→ 0 total
Exercise/Conversion
Innoviva, Inc.$INVA
Common Stock
2013-05-29$3.10/sh+4,570→ 207,254 total
Exercise/Conversion
Innoviva, Inc.$INVA
Common Stock
2013-05-29$12.40/sh+6,451→ 213,705 total
Exercise/Conversion
Innoviva, Inc.$INVA
Stock Option (Right to Buy)
2013-05-29−4,570→ 0 total

Companies

Recent Filings

Address

THERAVANCE, INC. 901 GATEWAY BLVD.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov